Elwen, F.R., Huskinson, A., Clapham, L., Bottomley, M.J., Heller, S.R., James, C., Abbas, A., Baxter, P. and Ajjan, R.A. (2015) An Observational Study of Patient Characteristics and Mortality Following Hypoglycemia in the Community. BMJ Open Diabetes Research & Care, 3, Article ID: e000094.

has been cited by the following article:

• TITLE: Improved All Cause and Cardiovascular Mortality and Morbidity by Empagliflozin: Too Good to Be True!

  AUTHORS: Udaya M. Kabadi

  KEYWORDS: Review Paper

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.6 No.2, April 20, 2016

  ABSTRACT: It was interesting to read the recent article regarding the efficacy of Empagliflozin in reducing all cause and cardiovascular mortality [1]. Superficially, the report appears to be very promising. However, the methodology, the results and the conclusions deserve and need further scrutiny and validation for several reasons.